Research Article

International Burden of Chronic Kidney Disease and Secondary Hyperparathyroidism: A Systematic Review of the Literature and Available Data

Table 7

Unadjusted incidence, prevalence, and survival of all renal replacement therapy populations, combined.

CountryReferenceSourceYear(s) of surveyAges surveyed (years)Incidence (pmp)Prevalence (pmp)Survival (%)

Europe
 DenmarkERA-EDTA [18]Registry2012All115.8a872.31 yr: 85.3c
 FranceERA-EDTA [18]Registry2012All142.2a1138.7
 GermanyFrei et al. [31]Registry2006All2131114
 GreeceERA-EDTA [18]Registry2012All185.6a1135.71 yr: 85.3c
 ItalyERA-EDTA [18]Registry2010All905.91 yr: 85.3c
 PortugalERA-EDTA [18]Registry2012All207.3a1670.2
 Russian FederationERA-EDTA [18], USRDS [25]Registry2012All48.1213.9
 SpainERA-EDTA [18]Registry2012All93.0–138.6a1092.11 yr: 85.3c
 SwedenERA-EDTA [18]Registry2012All101.8a933.01 yr: 85.3c
 NetherlandsERA-EDTA [18]Registry2012All112.9a923.41 yr: 85.3c
 United KingdomUKRR [19]Registry2012≥20100.0a867.11 yr: 87.3a
Asia
 ChinaZuo et al. [30]Survey2008All36.1
 Hong KongHo et al. [28]Registry1995–2011All1571152.5
 India Modi and Jha [29]Survey2008All160b
 JapanUSRDS [25]Registry2011All295
 Republic of KoreaKorean ESRD Registry [35]Registry2013All234.01446.4
 TurkeyERA-EDTA [18]Registry2012All138.6815.6
Oceania
 AustraliaANZDATA [26]Registry2012All112919
The Americas
 BrazilRosa-Diez [27]Registry2010All173.7708.7
 CanadaCORR [24]Registry2012All155.71,182.7
 MexicoRosa-Diez [27]Registry2010All458.0974.9
 United StatesUSRDS [25]Registry2012All358.61968.21 yr: 79.1
5yr: 41.0

—: data not available.
ANZDATA: The Australia and New Zealand Dialysis and Transplant Registry; CORR: Canadian Organ Replacement Register; ERA-EDTA: European Renal Association-European Dialysis and Transplant Association; JSDT: Japanese Society for Dialysis Therapy; LADTR: Latin American Dialysis and Transplant Registry; UKRR: UK Renal Registry; USRDS: United States Renal Data System.
aIncidence at day 91.
bRegional estimate used as proxy for national estimate.
cSurvival estimate is a combined multination estimate from ERA-EDTA; survival from day 91 forward.